Abbott India (500488) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
12 Feb, 2026Executive summary
Unaudited financial results for the quarter and nine months ended December 31, 2025, were approved by the Board of Directors on February 12, 2026.
Limited review report by statutory auditors found no material misstatements.
Re-appointment of Deloitte Touche Tohmatsu India LLP as internal auditors for FY 2026-27 was approved.
Financial highlights
Revenue from operations for the quarter ended December 31, 2025, was ₹1,724.04 crore, compared to ₹1,614.28 crore in the same quarter last year.
Profit before tax for the quarter was ₹508.98 crore, up from ₹487.59 crore year-over-year.
Net profit for the quarter was ₹373.31 crore, compared to ₹360.79 crore in the prior year quarter.
For the nine months ended December 31, 2025, revenue was ₹5,219.54 crore and net profit was ₹1,157.09 crore.
Earnings per share for the quarter stood at ₹176.92, up from ₹169.78 year-over-year.
Outlook and guidance
The company continues to monitor the impact of new labour codes and will account for any further changes as per applicable standards.
Latest events from Abbott India
- Q1 FY25 saw strong revenue and profit growth, with EPS up 13% year-over-year.500488
Q1 24/2520 Nov 2025 - Quarterly profit and revenue increased year-over-year, with strong cash and no audit concerns.500488
Q2 24/2520 Nov 2025 - Strong revenue and profit growth with robust cash flows and clean audit for Q2 FY26.500488
Q2 25/266 Nov 2025 - Strong revenue and profit growth with robust margins and clean audit for the latest quarter.500488
Q3 24/2525 Aug 2025 - Net profit rose to ₹1,414.44 crore with a higher dividend and strong cash flow for FY25.500488
Q4 24/2525 Aug 2025 - Revenue and profit rose year-over-year, with strong EPS growth and clean auditor review.500488
Q1 25/2625 Aug 2025